...
首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines
【24h】

Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines

机译:新型低密度脂蛋白 - 胆固醇评估对次级非高密度脂蛋白-C和载脂蛋白B靶标准的含量的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Selected dyslipidemia guidelines recommend non-high-density lipoprotein-cholesterol (non-HDL-C) and apolipoprotein B (apoB) as secondary targets to the primary target of low-density lipoprotein-cholesterol (LDL-C). After considering 2 LDL-C estimates that differ in accuracy, we examined: (1) how frequently non-HDL-C guideline targets could change management; and (2) the utility of apoB targets after meeting LDL-C and non-HDL-C targets.
机译:背景:选定的血脂血症指南推荐非高密度脂蛋白 - 胆固醇(非HDL-C)和载脂蛋白B(Apob)作为次级靶向低密度脂蛋白 - 胆固醇(LDL-C)的初级靶标。 在考虑2 LDL-C准确性的估计后,我们检查了:(1)非HDL-C指南目标的频率如何变为管理; (2)满足LDL-C和非HDL-C目标后APOB目标的效用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号